Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

2.

Dobutamine-stress echocardiography speckle-tracking imaging in the assessment of hemodynamic significance of coronary artery stenosis in patients with moderate and high probability of coronary artery disease.

Rumbinaitė E, Žaliaduonytė-Pekšienė D, Vieželis M, Čeponienė I, Lapinskas T, Žvirblytė R, Venclovienė J, Morkūnaitė K, Bielinis A, Šlapikas R, Vaškelytė JJ.

Medicina (Kaunas). 2016;52(6):331-339. doi: 10.1016/j.medici.2016.11.005. Epub 2016 Nov 25.

3.

Early and late diastolic strain rate vs global longitudinal strain at rest and during dobutamine stress for the assessment of significant coronary artery stenosis in patients with a moderate and high probability of coronary artery disease.

Rumbinaite E, Zaliaduonyte-Peksiene D, Lapinskas T, Zvirblyte R, Karuzas A, Jonauskiene I, Viezelis M, Ceponiene I, Gustiene O, Slapikas R, Vaskelyte JJ.

Echocardiography. 2016 Oct;33(10):1512-1522. doi: 10.1111/echo.13282. Epub 2016 Jun 16.

PMID:
27307201

Supplemental Content

Loading ...
Support Center